Interaction between CCL18 and GPR30 differs from the interaction between estradiol and GPR30

R Schmidt-Wolf, G Zissel - Anticancer Research, 2020 - ar.iiarjournals.org
Background/Aim: CC motif chemokine ligand 18 (CCL18) is overexpressed in the
microenvironment of tumors, promotes invasion and metastasis and is thus important for the …

The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer

YJ Guo, YJ Zhou, XL Yang, ZM Shao, ZL Ou - Biochemical and biophysical …, 2017 - Elsevier
Background Chemokine (CXC motif) ligand 17 (CXCL17) is the latest member of the
chemokine family. However, its function in various cancer types is unknown. The G protein …

CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway

H Lin, S Sun, X Lu, P Chen, C Chen, W Liang… - International …, 2017 - Elsevier
CCR10, a member of the chemokine receptor subfamily, is overexpressed in several tumors
and play a crucial role in cancer development and progression. However, the functions of …

[HTML][HTML] Upregulation of CC chemokine receptor type 7 expression by membrane-associated prostaglandin E synthase-1/prostaglandin E2 requires glycogen …

S Yu, Q Hou, H Sun, J Liu, J Li - Molecular medicine …, 2015 - spandidos-publications.com
CC chemokine receptor type 7 (CCR7) is involved in the development and progressions of
chronic inflammatory diseases and cancer; therefore, signaling pathways that regulate …

Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells

R Lappano, C Rosano, P De Marco… - Molecular and cellular …, 2010 - Elsevier
Estrogens are structurally related steroids that regulate important physiological processes.
17β-estradiol (E2) is reversibly oxidized to estrone (E1) and both E2 and E1 can be …

[HTML][HTML] CCR9 in cancer: oncogenic role and therapeutic targeting

Z Tu, R Xiao, J Xiong, KM Tembo, X Deng… - Journal of hematology & …, 2016 - Springer
Cancer is currently one of the leading causes of death worldwide and is one of the most
challenging major public health problems. The main challenges faced by clinicians in the …

[HTML][HTML] The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation

N Salazar, D Muñoz, G Kallifatidis, RK Singh, M Jordà… - Molecular cancer, 2014 - Springer
Background Recent advances have revealed a significant contribution of chemokines and
their receptors in tumor growth, survival after chemotherapy, and organ-specific metastasis …

[HTML][HTML] EGFR/Ras-induced CCL20 production modulates the tumour microenvironment

A Hippe, SA Braun, P Oláh, PA Gerber, A Schorr… - British journal of …, 2020 - nature.com
Background The activation of the EGFR/Ras-signalling pathway in tumour cells induces a
distinct chemokine repertoire, which in turn modulates the tumour microenvironment …

CCR9 and CCL25: A review of their roles in tumor promotion

B Xu, C Deng, X Wu, T Ji, L Zhao, Y Han… - Journal of cellular …, 2020 - Wiley Online Library
Chemokines constitute a superfamily of small chemotactic cytokines with functions that are
based on interactions with their corresponding receptors. It has been found that, among …

[HTML][HTML] Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol

R Girgert, G Emons, C Gründker - BMC cancer, 2014 - Springer
Background Due to the lack of ERα, triple negative breast cancers (TNBCs) are not
susceptible to endocrine therapy using antiestrogens. However, the majority of TNBCs …